Chapter/Section Purchase

1 Study Coverage
1.1 Somatostatin Receptor Type 4 Product Introduction
1.2 Market by Type
1.2.1 Global Somatostatin Receptor Type 4 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CNTX-0290
1.2.3 NNC-26910
1.2.4 Veldoreotide
1.2.5 Others
1.3 Market by Application
1.3.1 Global Somatostatin Receptor Type 4 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Alzheimer's Disease
1.3.3 Cognitive Disorders
1.3.4 Neuroendocrine Tumors
1.3.5 Acromegally
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Somatostatin Receptor Type 4 Sales Estimates and Forecasts 2017-2028
2.2 Global Somatostatin Receptor Type 4 Revenue Estimates and Forecasts 2017-2028
2.3 Global Somatostatin Receptor Type 4 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Somatostatin Receptor Type 4 Sales by Region
2.4.1 Global Somatostatin Receptor Type 4 Sales by Region (2017-2022)
2.4.2 Global Sales Somatostatin Receptor Type 4 by Region (2023-2028)
2.5 Global Somatostatin Receptor Type 4 Revenue by Region
2.5.1 Global Somatostatin Receptor Type 4 Revenue by Region (2017-2022)
2.5.2 Global Somatostatin Receptor Type 4 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Somatostatin Receptor Type 4 Sales by Manufacturers
3.1.1 Global Top Somatostatin Receptor Type 4 Manufacturers by Sales (2017-2022)
3.1.2 Global Somatostatin Receptor Type 4 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Somatostatin Receptor Type 4 in 2021
3.2 Global Somatostatin Receptor Type 4 Revenue by Manufacturers
3.2.1 Global Somatostatin Receptor Type 4 Revenue by Manufacturers (2017-2022)
3.2.2 Global Somatostatin Receptor Type 4 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Somatostatin Receptor Type 4 Revenue in 2021
3.3 Global Somatostatin Receptor Type 4 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Somatostatin Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Somatostatin Receptor Type 4 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Somatostatin Receptor Type 4 Sales by Type
4.1.1 Global Somatostatin Receptor Type 4 Historical Sales by Type (2017-2022)
4.1.2 Global Somatostatin Receptor Type 4 Forecasted Sales by Type (2023-2028)
4.1.3 Global Somatostatin Receptor Type 4 Sales Market Share by Type (2017-2028)
4.2 Global Somatostatin Receptor Type 4 Revenue by Type
4.2.1 Global Somatostatin Receptor Type 4 Historical Revenue by Type (2017-2022)
4.2.2 Global Somatostatin Receptor Type 4 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Somatostatin Receptor Type 4 Revenue Market Share by Type (2017-2028)
4.3 Global Somatostatin Receptor Type 4 Price by Type
4.3.1 Global Somatostatin Receptor Type 4 Price by Type (2017-2022)
4.3.2 Global Somatostatin Receptor Type 4 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Somatostatin Receptor Type 4 Sales by Application
5.1.1 Global Somatostatin Receptor Type 4 Historical Sales by Application (2017-2022)
5.1.2 Global Somatostatin Receptor Type 4 Forecasted Sales by Application (2023-2028)
5.1.3 Global Somatostatin Receptor Type 4 Sales Market Share by Application (2017-2028)
5.2 Global Somatostatin Receptor Type 4 Revenue by Application
5.2.1 Global Somatostatin Receptor Type 4 Historical Revenue by Application (2017-2022)
5.2.2 Global Somatostatin Receptor Type 4 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Somatostatin Receptor Type 4 Revenue Market Share by Application (2017-2028)
5.3 Global Somatostatin Receptor Type 4 Price by Application
5.3.1 Global Somatostatin Receptor Type 4 Price by Application (2017-2022)
5.3.2 Global Somatostatin Receptor Type 4 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Somatostatin Receptor Type 4 Market Size by Type
6.1.1 North America Somatostatin Receptor Type 4 Sales by Type (2017-2028)
6.1.2 North America Somatostatin Receptor Type 4 Revenue by Type (2017-2028)
6.2 North America Somatostatin Receptor Type 4 Market Size by Application
6.2.1 North America Somatostatin Receptor Type 4 Sales by Application (2017-2028)
6.2.2 North America Somatostatin Receptor Type 4 Revenue by Application (2017-2028)
6.3 North America Somatostatin Receptor Type 4 Market Size by Country
6.3.1 North America Somatostatin Receptor Type 4 Sales by Country (2017-2028)
6.3.2 North America Somatostatin Receptor Type 4 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Somatostatin Receptor Type 4 Market Size by Type
7.1.1 Europe Somatostatin Receptor Type 4 Sales by Type (2017-2028)
7.1.2 Europe Somatostatin Receptor Type 4 Revenue by Type (2017-2028)
7.2 Europe Somatostatin Receptor Type 4 Market Size by Application
7.2.1 Europe Somatostatin Receptor Type 4 Sales by Application (2017-2028)
7.2.2 Europe Somatostatin Receptor Type 4 Revenue by Application (2017-2028)
7.3 Europe Somatostatin Receptor Type 4 Market Size by Country
7.3.1 Europe Somatostatin Receptor Type 4 Sales by Country (2017-2028)
7.3.2 Europe Somatostatin Receptor Type 4 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Somatostatin Receptor Type 4 Market Size by Type
8.1.1 Asia Pacific Somatostatin Receptor Type 4 Sales by Type (2017-2028)
8.1.2 Asia Pacific Somatostatin Receptor Type 4 Revenue by Type (2017-2028)
8.2 Asia Pacific Somatostatin Receptor Type 4 Market Size by Application
8.2.1 Asia Pacific Somatostatin Receptor Type 4 Sales by Application (2017-2028)
8.2.2 Asia Pacific Somatostatin Receptor Type 4 Revenue by Application (2017-2028)
8.3 Asia Pacific Somatostatin Receptor Type 4 Market Size by Region
8.3.1 Asia Pacific Somatostatin Receptor Type 4 Sales by Region (2017-2028)
8.3.2 Asia Pacific Somatostatin Receptor Type 4 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Somatostatin Receptor Type 4 Market Size by Type
9.1.1 Latin America Somatostatin Receptor Type 4 Sales by Type (2017-2028)
9.1.2 Latin America Somatostatin Receptor Type 4 Revenue by Type (2017-2028)
9.2 Latin America Somatostatin Receptor Type 4 Market Size by Application
9.2.1 Latin America Somatostatin Receptor Type 4 Sales by Application (2017-2028)
9.2.2 Latin America Somatostatin Receptor Type 4 Revenue by Application (2017-2028)
9.3 Latin America Somatostatin Receptor Type 4 Market Size by Country
9.3.1 Latin America Somatostatin Receptor Type 4 Sales by Country (2017-2028)
9.3.2 Latin America Somatostatin Receptor Type 4 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Somatostatin Receptor Type 4 Market Size by Type
10.1.1 Middle East and Africa Somatostatin Receptor Type 4 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Somatostatin Receptor Type 4 Revenue by Type (2017-2028)
10.2 Middle East and Africa Somatostatin Receptor Type 4 Market Size by Application
10.2.1 Middle East and Africa Somatostatin Receptor Type 4 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Somatostatin Receptor Type 4 Revenue by Application (2017-2028)
10.3 Middle East and Africa Somatostatin Receptor Type 4 Market Size by Country
10.3.1 Middle East and Africa Somatostatin Receptor Type 4 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Somatostatin Receptor Type 4 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Crinetics Pharmaceuticals Inc
11.1.1 Crinetics Pharmaceuticals Inc Corporation Information
11.1.2 Crinetics Pharmaceuticals Inc Overview
11.1.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Crinetics Pharmaceuticals Inc Recent Developments
11.2 Strongbridge Biopharma plc
11.2.1 Strongbridge Biopharma plc Corporation Information
11.2.2 Strongbridge Biopharma plc Overview
11.2.3 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Strongbridge Biopharma plc Somatostatin Receptor Type 4 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Strongbridge Biopharma plc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Somatostatin Receptor Type 4 Industry Chain Analysis
12.2 Somatostatin Receptor Type 4 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Somatostatin Receptor Type 4 Production Mode & Process
12.4 Somatostatin Receptor Type 4 Sales and Marketing
12.4.1 Somatostatin Receptor Type 4 Sales Channels
12.4.2 Somatostatin Receptor Type 4 Distributors
12.5 Somatostatin Receptor Type 4 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Somatostatin Receptor Type 4 Industry Trends
13.2 Somatostatin Receptor Type 4 Market Drivers
13.3 Somatostatin Receptor Type 4 Market Challenges
13.4 Somatostatin Receptor Type 4 Market Restraints
14 Key Findings in The Global Somatostatin Receptor Type 4 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer